Glaxo Wellcome Plc said Thursday its half year profits fell 45 percent to 723 million pounds Lrb dlrs 6.02 billion Rrb, mainly because it lost United States patents on two key medicines, but the Drugmaker encouraged investors with a bullish outlook for new products.
Glaxo Wellcome earnings fall but bright forecast lifts shares.